
#373 Recap Extravaganza 2022
The Curbsiders Internal Medicine Podcast
00:00
Is There a New Therapy for H.Pylori?
The Chlorithromycin-based triple therapy is not recommended anymore by the guidelines or Dr. Safari. There's a Bismuth-based quadruple therapy that can be tough for patients to tolerate. Rifabudin-containing therapy, Paul, I probably won't be prescribing that without conferring with one of my gastroenterology colleagues or ID colleagues. A new agent called Vanoeprazan seems very promising and they're already using it in Asia.
Transcript
Play full episode